Risk factors of long bone fracture in non-ambulatory cerebral palsy children

Hong Kong Medical Journal

Volumn 12, Issue 6, 2006, Pages 426-431

  Ko, C H ^a   Tse, P W T ^b   Chan, A K H ^a  

^a Caritas Medical Centre Hong Kong   (Hong Kong)

^b Greenfield Integrated Child Health and Neurodevelopmental Centre   (Hong Kong)

Author keywords

Cerebral palsy; Fractures, bone; Immobilization

Indexed keywords

ANTICONVULSIVE AGENT; VALPROIC ACID;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; CEREBRAL PALSY; CHILD; CONTROLLED STUDY; FEEDING BEHAVIOR; FEMALE; FEMUR FRACTURE; FIBULA FRACTURE; HEALTH STATUS; HUMAN; IMMOBILIZATION; LONG BONE; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; RISK FACTOR; SEIZURE; TIBIA FRACTURE;

ADOLESCENT; ANTICONVULSANTS; BODY WEIGHT; CASE-CONTROL STUDIES; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; FEMALE; FEMORAL FRACTURES; FIBULA; FRACTURES, BONE; HUMANS; MALE; MULTIVARIATE ANALYSIS; RISK FACTORS; TIBIAL FRACTURES;

EID: 33845656529     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sturm PF, Alman BA, Christie BL. Femur fractures in institutionalized patients after hip spica immobilization. J Pediatr Orthop 1993;13:246-8.
2. Henderson RC, Lark RK, Gurka MJ, et al. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 2002;110:e5.
3. Henderson RC. Bone density and other possible predictors of fracture risk in children and adolescents with spastic quadriplegia. Dev Med Child Neurol 1997;39:224-7.
4. Leung SS, Lau JT, Tse LY, Oppenheimer SJ. Weight-for-age and weight-for-height references for Hong Kong children from birth to 18 years. J Paediatr Child Health 1996;32:103-9.
5. Kay RM, Rethlefsen SA, Fern-Buneo A, Wren TA, Skaggs DL. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy. J Bone Joint Surg Am 2004;86:2377-84.
6. Ko CH, Kong CK, Tse PW. Valproic acid and thrombocytopenia: cross-sectional study. Hong Kong Med J 2001;7:15-21.
7. Samson-Fang L, Fung E, Stallings VA, et al. Relationship of nutritional status to health and societal participation in children with cerebral palsy. J Pediatr 2002;141:637-43.
8. Stallings VA, Cronk CE, Zemel BS, Charney EB. Body composition in children with spastic quadriplegic cerebral palsy. J Pediatr 1995;126:833-9.
9. Samson-Fang L, Stevenson RD. Linear growth velocity in children with cerebral palsy. Dev Med Child Neurol 1998;40:689-92.
10. Jevsevar DS, Karlin LI. The relationship between preoperative nutritional status and complications after an operation for scoliosis in patients who have cerebral palsy. J Bone Joint Surg Am 1993;75:880-4.
11. Lipton GE, Miller F, Dabney KW, Altiok H, Bachrach SJ. Factors predicting postoperative complications following spinal fusions in children with cerebral palsy. J Spinal Disord 1999;12:197-205.
12. Amundson JA, Sherbondy A, Van Dyke DC, Alexander R. Early identification and treatment necessary to prevent malnutrition in children and adolescents with severe disabilities. J Am Diet Assoc 1994;94:880-3.
13. Stasikelis PJ, Lee DD, Sullivan CM. Complications of osteotomies in severe cerebral palsy. J Pediatr Orthop 1999;19:207-10.
14. King W, Levin R, Schmidt R, Oestreich A, Heubi JE. Prevalence of reduced bone mass in children and adults with spastic quadriplegia. Dev Med Child Neurol 2003;45:12-6.
15. Crosley CJ, Chee C, Berman PH. Rickets associated with long-term anticonvulsant therapy in a pediatric outpatient population. Pediatrics 1975;56:52-7.
16. Hunt PA, Wu-Chen ML, Handal NJ, et al. Bone disease induced by anticonvulsant therapy and treatment with calcitriol (1,25-dihydroxyvitamin D3). Am J Dis Child 1986;140:715-8.
17. Keck E, Gollnick B, Reinhardt D, Karch D, Peerenboom H, Kruskemper HL. Calcium metabolism and vitamin D metabolite levels in children receiving anticonvulsant drugs. Eur J Pediatr 1982;139:52-5.
18. O'Hare JA, Duggan B, O'Driscoll D, Callaghan N. Biochemical evidence for osteomalacia with carbamazepine therapy. Acta Neurol Scand 1980;62:282-6.
19. Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;58:1348-53.
20. Sato Y, Kondo I, Ishida S, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 2001;57:445-9.
21. Sheth RD, Wesolowski CA, Jacob JC, et al. Effect of carbamazepine and valproate on bone mineral density. J Pediatr 1995;127:256-62.
22. Akin R, Okutan V, Sarící Ü, Altunbas A, Gokcay E. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol 1998;19:129-31.
23. Henderson RC, Lark RK, Kecskemethy HH, Miller F, Harcke HT, Bachrach SJ. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial. J Pediatr 2002;141:644-51.
24. Grissom LE, Kecskemethy HH, Bachrach SJ, McKay C, Harcke HT. Bone densitometry in pediatric patients treated with pamidronate. Pediatr Radiol 2005;35:511-7.
25. Allington N, Vivegnis D, Gerard P. Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study. Acta Orthop Belg 2005;71:91-7.